PAM
XFOR icon

Panagora Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History

Panagora Asset Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-35
Closed -$7K – 2403
2021
Q2 		$7K Sell
35
-435
-93% -$109K ﹤0.01% 2384
2021
Q1 		$121K Sell
470
-1,750
-79% -$460K ﹤0.01% 1897
2020
Q4 		$428K Sell
2,220
-20
-0.9% -$3.93K ﹤0.01% 1281
2020
Q3 		$455K Buy
2,240
+513
+30% +$123K ﹤0.01% 1200
2020
Q2 		$483K Buy
1,727
+1,350
+358% +$370K ﹤0.01% 1212
2020
Q1 		$113K Buy
377
+361
+2,256% +$102K ﹤0.01% 1657
2019
Q4 		$5K Hold
16
– – ﹤0.01% 2258
2019
Q3 		$6K Buy
16
+12
+300% +$4.75K ﹤0.01% 2264
2019
Q2 		$2K Buy
+4
New +$2.03K ﹤0.01% 2541

Other funds holding XFOR

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Panagora Asset Management's XFOR Position: Q3 2021 in Review

Panagora Asset Management sold out of X4 Pharmaceuticals (XFOR) in Q3 2021, closing a stake of 35 shares — an estimated $7K sold.

Panagora Asset Management first reported a position in XFOR in Q2 2019 and held it in 9 quarters. The position peaked at $483K in Q2 2020. 51 funds tracked by Wall St. Rank hold XFOR as of Q3 2021.

  • Panagora Asset Management reported no remaining X4 Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 35 X4 Pharmaceuticals shares in Q3 2021, an estimated $7K.
  • Panagora Asset Management first reported a position in X4 Pharmaceuticals in Q2 2019 and held it in 9 quarters.
  • Panagora Asset Management's X4 Pharmaceuticals position peaked at $483K in Q2 2020.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.